In renal cell carcinoma cell lines, CDKN1A knockdown increased p53 protein levels and sensitised cells to cisplatin‐induced apoptosis via p53 [23]. This evidence concerns the gene CDKN1A and hereditary clear cell renal cell carcinoma.